BIA
Biondo Investment Advisors Portfolio holdings
AUM
$759M
This Quarter Return
+5.49%
1 Year Return
+16.64%
3 Year Return
+102.11%
5 Year Return
+165.96%
10 Year Return
+637.5%
AUM
$346M
AUM Growth
+$346M
(+24%)
Cap. Flow
-$10.3M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
48.65%
Holding
94
New
18
Increased
35
Reduced
23
Closed
15
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$9.62M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.48M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$4.36M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$4.19M |
| 5 |
Lowe's Companies
LOW
|
$3.55M |
Top Sells
| 1 |
JPM.WS
JPMorgan Chase
JPM.WS
|
$19.5M |
| 2 |
Gilead Sciences
GILD
|
$8.83M |
| 3 |
Ford
F
|
$5.26M |
| 4 |
BAC.WS.A
Bank Of America Corporation Ws A
BAC.WS.A
|
$3.6M |
| 5 |
JPMorgan Chase
JPM
|
$2.99M |
Sector Composition
| 1 | Healthcare | 32.13% |
| 2 | Financials | 12.03% |
| 3 | Communication Services | 10.65% |
| 4 | Energy | 9.04% |
| 5 | Technology | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intuitive Surgical
ISRG
$170B
| $28.1M | 8.14% | 30,083 -2,569 | -8% | -$2.4M |
|
2
Mastercard
MA
$538B
| $24.6M | 7.1% | 202,224 -21,215 | -9% | -$2.58M |
|
3
Apple
AAPL
$3.45T
| $19.1M | 5.51% | 132,294 +12,608 | +11% | +$1.82M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $17.5M | 5.06% | 134,607 -7,215 | -5% | -$937K |
|
5
Meta Platforms (Facebook)
META
$1.86T
| $16.8M | 4.87% | 111,530 +1,355 | +1% | +$205K |
|
|
BAC.WS.A
6
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $14.8M | 4.27% | 1,226,880 -299,400 | -20% | -$3.6M |
|
|
JPM.WS
7
DELISTED
JPMorgan Chase
JPM.WS
| $13.6M | 3.93% | 270,282 -387,445 | -59% | -$19.5M |
|
8
Idexx Laboratories
IDXX
$51.8B
| $13.2M | 3.81% | 81,561 -1,130 | -1% | -$182K |
|
|
9
Alphabet (Google) Class A
GOOGL
$2.57T
| $11M | 3.18% | 11,828 +4,503 | +61% | +$4.19M |
|
|
ABMD
10
DELISTED
Abiomed Inc
ABMD
| $9.62M | 2.78% | +67,139 | New | +$9.62M |
|
|
11
JPMorgan Chase
JPM
$829B
| $8.87M | 2.56% | 97,001 -32,744 | -25% | -$2.99M |
|
12
Illumina
ILMN
$15.8B
| $7.84M | 2.27% | 45,198 +13,082 | +41% | +$2.27M |
|
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $7.61M | 2.2% | 15,485 +13,200 | +578% | +$6.48M |
|
14
Pacira BioSciences
PCRX
$1.2B
| $7.55M | 2.18% | 158,203 -6,419 | -4% | -$306K |
|
15
Schlumberger
SLB
$55B
| $6.71M | 1.94% | 101,157 +5,092 | +5% | +$338K |
|
16
Diamondback Energy
FANG
$43.1B
| $6.45M | 1.86% | 72,607 +1,392 | +2% | +$124K |
|
17
Bristol-Myers Squibb
BMY
$96B
| $6.27M | 1.81% | 112,458 -11,909 | -10% | -$664K |
|
18
VF Corp
VFC
$5.91B
| $5.31M | 1.54% | 92,173 +6,861 | +8% | +$395K |
|
19
Chevron
CVX
$324B
| $5.21M | 1.51% | 49,425 +1,532 | +3% | +$161K |
|
20
Philip Morris
PM
$260B
| $5.19M | 1.5% | 44,214 +1,631 | +4% | +$192K |
|
21
Lockheed Martin
LMT
$106B
| $4.94M | 1.43% | 17,685 -2,776 | -14% | -$776K |
|
22
3M
MMM
$82.8B
| $4.81M | 1.39% | 22,987 +902 | +4% | +$189K |
|
23
AbbVie
ABBV
$372B
| $4.55M | 1.32% | 62,766 +3,654 | +6% | +$265K |
|
24
Core Laboratories
CLB
$540M
| $4.42M | 1.28% | 43,637 +980 | +2% | +$99.2K |
|
|
EGRX
25
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.36M | 1.26% | +55,202 | New | +$4.36M |
|